Stockscreener 앱 받기
1.73
4.42%
-0.08
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Nuvation Bio’s SWOT analysis: FDA approval boosts stock prospects By Investing.com - Investing.com Nigeria
Nuvation Bio’s SWOT analysis: FDA approval boosts stock prospects - Investing.com
Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment - TipRanks
Nuvation Bio stock holds steady as FDA approves lung cancer drug - Investing.com
Nuvation Bio price target maintained at $6 by Citizens JMP - Investing.com South Africa
FDA Approves Nuvation Bio’s Ibtrozi for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer - PharmExec
'Life is too short to work on things that are mediocre': Why this biotech CEO's 2nd drug approval is a big deal - The Business Journals
U.S. FDA Approves Nuvation Bio’s Ibtrozi - Contract Pharma
Nuvation Scores First FDA Nod With Oral Lung Cancer Drug - BioSpace
Nuvation Bio (NUVB) Shares Decline Despite FDA Approval of Ibtro - GuruFocus
FDA approves Nuvation Bio’s TKI inhibitor Ibtrozi to treat rare form of lung cancer - PMLiVE
Nuvation Bio stock falls after FDA approves lung cancer drug By Investing.com - Investing.com Canada
FDA approves Nuvation Bio’s Ibtrozi for ROS1-positive NSCLC - The Pharma Letter
Nuvation Bio stock falls after FDA approves lung cancer drug - Investing.com
Nuvation Bio granted FDA approval for lung cancer therapy Ibtrozi - MSN
Nuvation Bio (NUVB) Gains FDA Approval for Lung Cancer Drug Ibtr - GuruFocus
Nuvation Bio (NUVB) Trading Halted Amidst Anticipated Announceme - GuruFocus
FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche - BioPharma Dive
Nuvation Bio’s IBTROZI Receives FDA Approval - TipRanks
Nuvation Bio (NUVB) Gains FDA Approval for Advanced Lung Cancer Drug IBTROZI | NUVB Stock News - GuruFocus
Nuvation Bio (NUVB) Stock Rating Maintained at Outperform by Wed - GuruFocus
Nuvation Bio (NUVB) Stock Rating Maintained at Outperform by Wedbush | NUVB Stock News - GuruFocus
US FDA approves Nuvation Bio’s lung cancer therapy - WSAU
US FDA approves Nuvation Bio's rare lung cancer drug - Reuters
Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval - Benzinga
Nuvation Bio (NUVB) Gets Boost as FDA Approves Ibtrozi for Lung - GuruFocus
Nuvation Bio (NUVB) Shares Decline Despite FDA Approval of Ibtrozi | NUVB Stock News - GuruFocus
# FDA approves Nuvation Bio’s lung cancer drug taletrectinib - Investing.com
Nuvation Bio (NUVB) Trading Resumes | NUVB Stock News - GuruFocus
Nuvation Bio (NUVB) Gets Boost as FDA Approves Ibtrozi for Lung Cancer | NUVB Stock News - GuruFocus
Nuvation Bio scores first FDA approval for new lung cancer drug - Endpoints News
Nuvation Bio (NUVB) Gains FDA Approval for Advanced Lung Cancer - GuruFocus
Nuvation kinase inhibitor wins FDA approval in non-small cell lung cancer - TipRanks
Nuvation Bio stock in focus as FDA clears Ibtrozi (NUVB:NYSE) - Seeking Alpha
Nuvation Bio announces FDA approval of Ibtrozi for advanced ROS-1+ NSCLC - TipRanks
FDA Grants Approval to Nuvation Bio's Ibtrozi for Lung Cancer Treatment (NUVB) | NUVB Stock News - GuruFocus
U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer - Business Wire
Nuvation Bio (NUVB) Shares Surge Following FDA Approval | NUVB Stock News - GuruFocus
US FDA approves Nuvation Bio's lung cancer therapy - TradingView
Nuvation Bio Stock Trading Halted, Pending Material News Release - marketscreener.com
FDA announces apporval of Nuvation Bio’s Ibtrozi for lung cancer - TipRanks
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $925,000 Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio: Judgement Day Grows Closer (NYSE:NUVB) - Seeking Alpha
Nuvation Bio (NYSE:NUVB) Raised to “Hold” at Wall Street Zen - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Squarepoint Ops LLC - Defense World
NUVB Stock Price and Chart — NYSE:NUVB - TradingView
ProShare Advisors LLC Acquires 16,801 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
BNP Paribas Financial Markets Purchases New Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio’s (NUVB) “Market Outperform” Rating Reaffirmed at JMP Securities - Defense World
Nuvation Bio (NUVB) Price Target Maintained at $6 by JMP Securit - GuruFocus
Nuvation Bio (NUVB) Price Target Maintained at $6 by JMP Securities | NUVB Stock News - GuruFocus
JMP maintains $6 target on Nuvation Bio stock ahead of PDUFA - Investing.com Nigeria
JMP maintains $6 target on Nuvation Bio stock ahead of PDUFA By Investing.com - Investing.com South Africa
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Nuveen Asset Management LLC - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $276,000 Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Deutsche Bank AG Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Citizens JMP highlights key ASCO presentations - Investing.com
Citizens JMP highlights key ASCO presentations By Investing.com - Investing.com UK
D. E. Shaw & Co. Inc. Sells 63,827 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Millennium Management LLC - Defense World
Nuvation Bio stockholders approve board members and executive pay By Investing.com - Investing.com India
1.91%
1.17%
자본화:
|
볼륨(24시간):